FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 67 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $40,000 | -51.8% | 10,701 | -53.8% | 0.00% | -60.0% |
| Q4 2018 | $83,000 | -20.2% | 23,172 | +14.0% | 0.01% | +25.0% |
| Q1 2018 | $104,000 | +23.8% | 20,321 | +11.0% | 0.00% | 0.0% |
| Q2 2017 | $84,000 | -3.4% | 18,308 | +36.2% | 0.00% | 0.0% |
| Q1 2016 | $87,000 | -65.5% | 13,440 | -56.8% | 0.00% | -66.7% |
| Q4 2015 | $252,000 | -34.0% | 31,140 | -16.6% | 0.01% | -7.7% |
| Q2 2015 | $382,000 | +210.6% | 37,339 | +180.1% | 0.01% | +225.0% |
| Q1 2015 | $123,000 | +26.8% | 13,331 | -4.1% | 0.00% | 0.0% |
| Q4 2014 | $97,000 | – | 13,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |